These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 26002889)

  • 41. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty.
    Tzivoni D; Koukoui D; Guetta V; Novack L; Cowing G;
    Am J Cardiol; 2008 Mar; 101(6):753-7. PubMed ID: 18328834
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Planer D; Mehran R; Ohman EM; White HD; Newman JD; Xu K; Stone GW
    Circ Cardiovasc Interv; 2014 Jun; 7(3):285-93. PubMed ID: 24847016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of myocardial damage prior to hospital admission among patients with acute chest pain or other symptoms raising a suspicion of acute coronary syndrome.
    Svensson L; Isaksson L; Axelsson C; Nordlander R; Herlitz J
    Coron Artery Dis; 2003 May; 14(3):225-31. PubMed ID: 12702926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
    Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
    Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
    Hallén J; Buser P; Schwitter J; Petzelbauer P; Geudelin B; Fagerland MW; Jaffe AS; Atar D
    Am J Cardiol; 2009 Dec; 104(11):1472-7. PubMed ID: 19932777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal elevation of myocardial necrosis biomarkers after coronary artery bypass grafting without established myocardial infarction assessed by cardiac magnetic resonance.
    Oikawa FTC; Hueb W; Nomura CH; Hueb AC; Villa AV; da Costa LMA; de Melo RMV; Rezende PC; Segre CAW; Garzillo CL; Lima EG; Ramires JAF; Filho RK
    J Cardiothorac Surg; 2017 Dec; 12(1):122. PubMed ID: 29284532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial.
    Ranchord AM; Argyle R; Beynon R; Perrin K; Sharma V; Weatherall M; Simmonds M; Heatlie G; Brooks N; Beasley R
    Am Heart J; 2012 Feb; 163(2):168-75. PubMed ID: 22305833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.
    Hahn JY; Song YB; Kim EK; Yu CW; Bae JW; Chung WY; Choi SH; Choi JH; Bae JH; An KJ; Park JS; Oh JH; Kim SW; Hwang JY; Ryu JK; Park HS; Lim DS; Gwon HC
    Circulation; 2013 Oct; 128(17):1889-96. PubMed ID: 24068776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia.
    Lønborg J; Kelbæk H; Vejlstrup N; Bøtker HE; Kim WY; Holmvang L; Jørgensen E; Helqvist S; Saunamäki K; Terkelsen CJ; Schoos MM; Køber L; Clemmensen P; Treiman M; Engstrøm T
    Circ Cardiovasc Interv; 2012 Apr; 5(2):288-95. PubMed ID: 22496084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dobutamine-induced ST-segment elevation associated with a biphasic response of wall motion in patients with a recent myocardial infarction is caused by myocardial ischaemia and is abolished by revascularization of the infarct-related artery.
    Lanzarini L; Scelsi L; Canosi U; Klersy C; Sebastiani R; Previtali M
    Acta Cardiol; 2003 Dec; 58(6):527-33. PubMed ID: 14713178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
    Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ST-segment elevation during dobutamine stress testing predicts functional recovery after acute myocardial infarction.
    Piérard LA; Lancellotti P; Kulbertus HE
    Am Heart J; 1999 Mar; 137(3):500-11. PubMed ID: 10047633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial.
    Kaltoft A; Bøttcher M; Nielsen SS; Hansen HH; Terkelsen C; Maeng M; Kristensen J; Thuesen L; Krusell LR; Kristensen SD; Andersen HR; Lassen JF; Rasmussen K; Rehling M; Nielsen TT; Bøtker HE
    Circulation; 2006 Jul; 114(1):40-7. PubMed ID: 16801464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
    Selim NA; Hmouda HT
    Saudi Med J; 2002 May; 23(5):526-8. PubMed ID: 12070573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.